ACE-Breast-03: A phase II study patients with HER2-positive metastatic breast cancer whose disease is resistant or refractory to T-DM1, and/or T-DXd, and/or tucatinib-containing regimens treated with ARX788 Meeting Abstract
| Authors: | Hurvitz, S. A.; Kalinsky, K.; Tripathy, D.; Sledge, G.; Gradishar, W. J.; O'Shaughnessy, J.; Modi, S.; Park, H.; McCartney, A.; Frentzas, S.; Shannon, C.; Cuff, K.; Eek, R. W.; Martin Jimenez, M.; Curigliano, G.; Jerusalem, G.; Huang, C.; Press, M.; Lu, J. |
| Abstract Title: | ACE-Breast-03: A phase II study patients with HER2-positive metastatic breast cancer whose disease is resistant or refractory to T-DM1, and/or T-DXd, and/or tucatinib-containing regimens treated with ARX788 |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S662 |
| End Page: | S663 |
| Language: | English |
| ACCESSION: | WOS:000866211600267 |
| DOI: | 10.1016/j.annonc.2022.07.1857 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 273TiP -- Source: Wos |
